Best Practice Recommendations for Canadian Programs That Provide Harm Reduction Supplies to People Who Use Drugs and are At Risk for HIV, HCV, and Other Harms: 2021

Guide or handbook
par
Strike, C. et al

Date de publication

2021

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

The goal of the Best Practice Recommendations is to improve the effectiveness of programs that deliver harm reduction supplies to people who use drugs and are at risk for human immunodeficiency virus (HIV), hepatitis C (HCV), hepatitis B (HBV), overdose and other harms.

Constatations/points à retenir

These updated recommendations are a tool to transfer knowledge to develop, review, redesign, and evaluate programs. We hope to enable programs to use evidence to move towards best practices, if these are not already in place. While the ideal program would distribute all the supplies covered in the 2021 edition, an inability to do so should not be used to discourage development and implementation to the best of a program’s ability

Mots clés

Clinical guidance
Harm reduction
Policy/Regulatory
Wrap-around services
About prescribers
Illegal drugs
Injecting drugs